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Computer-aided diagnosis (CAD) systems have been proposed to assist radiologists in making diagnostic decisions by provid-
ing helpful information. As one of the most important sequences in prostate magnetic resonance imaging (MRI), image fea-
tures from T2-weighted images (T2WI) were extracted and evaluated for the diagnostic performances by using CAD. We ex-
tracted 12 quantitative image features from prostate T2-weighted MR images. The importance of each feature in cancer identi-
fication was compared in the peripheral zone (PZ) and central gland (CG), respectively. The performance of the comput-
er-aided diagnosis system supported by an artificial neural network was tested. With computer-aided analysis of T2-weighted 
images, many characteristic features with different diagnostic capabilities can be extracted. We discovered most of the features 
(10/12) had significant difference (P<0.01) between PCa and non-PCa in the PZ, while only five features (sum average, mini-
mum value, standard deviation, 10th percentile, and entropy) had significant difference in CG. CAD prediction by features 
from T2w images can reach high accuracy and specificity while maintaining acceptable sensitivity. The outcome is convictive 
and helpful in medical diagnosis. 
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Prostate cancer (PCa) is one of the most common malig-
nancies in elderly men worldwide. Its incidence and mortal-
ity rate are rising, which is particularly prominent in an ag-
ing society [14]. MR imaging depicts the anatomy of the 
prostate with exquisite detail because of its high spatial res-
olution, superior soft-tissue contrast resolution, and multi- 
planar capability. It is the most accurate noninvasive meth-
od for PCa detection and can also aid local and distant stag-
ing [58]. 
T2-weighted images (T2WI) is an essential sequence 
used in the diagnosis of PCa [911]. No matter how many 
sequences are combined to detect PCa, T2WI is always the 
indispensable one [12,13]. Typical PCa and non-cancer can 
be differentiated by T2WI. Traditional MR cancer detection 
mainly relies on the low signal intensity in T2WI, especially 
for the tumours located at the peripheral zone (PZ), which 
count for 70%75% of all PCa [14].  
Subjective interpretation of MR images depends on radi-
ologists’ experience and expertise, limiting the accuracy of 
PCa detection. The inter-observer variability may result in 
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totally different decisions from the same set of images 
[15,16]. Standard and extensive training is needed to im-
prove diagnostic accuracy. However, even an experienced 
radiologist may still miss some inner characteristics. Com-
puter-aided diagnosis (CAD) [17], in which computer anal-
ysis methods are used to help radiologists detect and diag-
nose, has the potential to address these challenges. Seltzer et 
al. [18] confirmed that a combined radiologist-computer 
system substantially improved accuracy of body MR radi-
ologists in the diagnosis of PCa.  
Due to the quantitative feature of CAD analysis, it has 
been developed for breast, lung, and colorectal cancers 
[1921], but there has been limited application to PCa, and 
even rare analysis to T2WI.  
The main objective of this study was to extract image 
features from prostate T2WI and evaluate their diagnostic 
performances by CAD. 
1  Materials and methods 
1.1  Study population 
Between December 2008 and January 2010, 71 consecutive 
patients who were suspected of PCa in the prostate MR da-
tabase were selected for the retrospective study. Among 
them, 35 patients were confirmed to have PCa by biopsy, 
and the other 36 patients had not been detected of cancer by 
serial biopsy and long-term follow-up (12 to 59 months, 
mean 32 months). 
Inclusion criteria for the study were as follows: (i) there 
were complete prostate MR data including T2WI; (ii) the 
clinical information contained age, total prostate specific 
antigen (tPSA), free prostate specific antigen/total prostate 
specific antigen (fPSA/tPSA), ultrasound, and digital rectal 
examination; (iii) subsequent ultrasound-guided biopsy was 
performed within 3 months after the MR scan; (iv) all the 
patients underwent a long-term follow-up. Exclusion crite-
ria were as follows: (i) ultrasound-guided biopsy was per-
formed within 3 months before the MR scan; (ii) the pa-
tients were previously diagnosed with PCa or prostate sar-
coma; (iii) there was treatment before the MR scan, such as 
hormone therapy, radiotherapy, and surgery. 
1.2  MR image data acquisition 
All MR examinations were carried out on a 1.5 Tesla MR 
scanner (Signa TM; GE Medical Systems, Milwaukee, WI, 
USA) using a pelvic phased-array coil (GE Medical Sys-
tems). All routine prostate MR examinations followed 
standardised protocols. T2-weighted turbo-spin-echo imag-
es were obtained in the axial, sagittal, and coronal planes 
without fat suppression with TR: 3500 ms; TE: 85 ms; FOV: 
240 mm×240 mm; matrix: 320×256; slice thickness: 4 mm 
with no gap; number of signals acquired: 4. 
1.3  ROIs selection 
Firstly, regions of interest (ROIs) with 1520 mm2 within a 
sextant were manually delineated in the prostate T2WI. 
ROIs were drawn in the most suspected regions at T2WI by 
two experienced radiologists (7 and 9 years of prostate MR 
experience) without reference to histopathology. If the re-
gion was absolutely normal (no signs of cancer or inflam-
mation), a ROI was put in the mirror position of the contra-
lateral area. The two experienced radiologists also graded 
the overall score subjectively (5-point scale: 1-definitely 
benign; 2-probably benign; 3-indeterminate; 4-probably 
malignant; and 5-definitely malignant) of each ROI accord-
ing to European Society of Urogenital Radiology (ESUR) 
prostate guidelines [22] without reference to histopathology. 
Then, cancerous ROIs were defined as the ROIs within a 
sextant that was positive at biopsy, while the non-cancerous 
ROIs were defined as the ROIs within a sextant that was 
negative at biopsy, either an inflammation area or a normal 
area. In total, 238 ROIs were selected from the PZ (146 
non-cancerous and 92 cancerous ROIs) and 188 ROIs were 
selected from the central gland (CG) (136 non-cancerous 
and 52 cancerous ROIs). The distribution of ROIs selected 
from the T2WI is summarised in Table 1. 
1.4  Computer-extracted features 
The general data flow diagram of this CAD system can be 
divided into three main steps (Figure 1): data preparation 
(images acquisition and annotate MR images), parameters 
preparation (feature extraction and selection), and predic-
tion (based on artificial neural networks (ANN) classifier) 
and evaluation (via cross-validation). All were performed 
with an in-house computer software.   
Before analysis, T2WI were standardised to correct for 
background and nonlinearity of the MR image intensity 
scale [23]. Quantified features in this study were grouped 
into three types: general features (mean value, minimum 
value, standard deviation, coefficient of variation, 10th per-
centile), features derived from gray-level histogram (skew-
ness, kurtosis), and features derived from co-occurrence 
matrix (GLCM) (contrast, correlation, energy, homogeneity, 
entropy) (see Supporting Information). In total, 12 features 
were extracted from the T2WI. A summary of these features 
and their descriptions are given in Table 2. 
Table 1  The distribution of ROIs in the peripheral zone and central glanda) 
Peripheral zone Central gland Whole gland 
PCa 92 52 144 
Non-PCa 146 136 282 
Total 238 188 426 
a) PCa, prostate cancer; ROIs, regions of interest.













Data preparation Parameters preparation Prediction and evaluation  
Figure 1 (color online)  General data flow diagram of this CAD system. 
Table 2  List of features extracted from T2-weighted images 
Type  Features  Description  
General features 
Sum average Measure of overall image brightness 
Minimum value Measure of the darkest brightness of the image 
Standard deviation Measure of how spread out the gray-level distribution is 
Coefficient of  
variation  
Normalised measure of dispersion of the gray-level distribution 
Gray-level Histogram 
10th percentile Measure of the value below which are 10%  of the cumulative probability values 
Skewness Measure of the asymmetry of the data around the sample mean 
Kurtosis Measure of how outlier-prone a distribution is 
Gray-level co-occurrence matrix [34] 
Contrast Measure of the local variations in the gray-level co-occurrence matrix. 
Correlation Measure of the joint probability occurrence of the specified pixel pairs 
Energy Measure of the sum of squared elements in the GLCM 
Homogeneity  
Measures the closeness of the distribution of elements in the GLCM to the GLCM diago-
nal 
Entropy  Measure of randomness of gray-levels 
 
1.5  Feature selection 
To select the most informative set of features, sequential 
forward selection (SFS) was performed with an ANN clas-
sifier. Prediction error was used as a selection criterion. An 
SFS algorithm is a bottom-up search procedure which starts 
from an empty feature set and gradually adds features se-
lected by some evaluation function that minimises the mean 
square error (MSE). Another goal of feature selection was 
to preserve the robustness of the classification method and 
reduce the risk of over-fitting [24]. 
1.6  Classifier design 
A devised feed forward ANN structure with three layers 
(input layer, hidden layer, and output layer) was used as a 
classifier to identify PCa (Figure 2). The selected features 
were used as the inputs of the classifier, and the output was 
the prediction of PCa (between 0 and 1). ROIs in the PZ and 
CG were trained and tested separately.  
In order to improve the characteristics of this classifier, a 
back-propagation (BP) algorithm was used in the training 
procedure, and the Levenberg-Marquardt (LM) algorithm 
was applied as a learning rule. Different transfer functions 
were tried in the hidden and output layers, the log-arithmic- 
sigmoid (Logsig) was finally selected as the transfer func-
tion. The network structure with a hidden layer of 14 neu-
rons and the epoch number of 500 was used. At the end, the 
network structure that yielded the best classification is given 
in Table 3. 











Figure 2 (color online)  Schematic diagram of this ANN classifier with 
three layers (input layer, hidden layer, and output layer). Three kinds of 
features (general features, texture features derived from gray-level histo-
gram, and co-occurrence matrix) were selected as the inputs, each of which 
were richly interconnected by weighed connection lines. The output of this 
classifier was the prediction of prostate cancer (between 0 and 1). 
1.7  Statistical analysis 
A leave-one-ROI-out cross-validation approach [25] was 
used to separate the dataset into a training set and a test set. 
With this method, each ROI was used to test the classifier 
one time, while the others were used to train the classifier. 
This procedure was repeated until all of the 426 ROIs had 
been tested. Receiver operating characteristic (ROC) curve 
analysis was performed to evaluate the performance of this  
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Table 3  The parameters of this devised ANN classifier structure 
Parameters  Properties  
Training algorithm  Back-propagation (BP)  
Layers  3  
Number of neurons in the input layer  5  
Number of neurons in the hidden layer  14  
Number of neurons in the output layer 1  
Learning rate  0.1  
Epoch number  500  
Learning algorithm  Levenberg-Marquardt (LM)  
Transfer function  Logarithmic-sigmoid (Logsig) 
 
CAD system [2628], and two radiologists’ scores were 
used for comparison. Areas under the ROC curves (AUC), 
sensitivity, specificity, positive predictive values (PPV), 
negative predictive values (NPV), and accuracy were uti-
lised to evaluate the performance of this CAD system. All 
statistical tests were two sided, and P<0.01 was considered 
to indicate significant difference. 
2  Results 
Among the 71 patients recruited in our study, 35 (mean age 
68.8±8.9 years, range 4082 years; tPSA 60.5±77.8 ng 
mL1, range 5.6297.3 ng mL1) were confirmed to have 
PCa by biopsy, while the other 36 patients (mean age 
67.8±6.4 years, range 5379 years; tPSA 11.7±8.1 ng mL1, 
range 0.8537.1 ng mL1) were not detected of PCa by seri-
al biopsy and long-term follow-up. 
The performance of features extracted from T2WI is 
shown in Table 4. Most of the features (10/12) had signifi-
cant difference (P<0.01) between PCa and non-PCa in the 
PZ, while only five features (sum average, minimum value, 
SD, 10th percentile, and entropy) had significant difference 
in CG. These five features had significant difference in both 
PZ and CG. The importance of different images’ features in 
PZ and CG is shown in Figure 3.  
After SFS selection, six features (sum average, minimum 
value, SD, 10th percentile, contrast, and correction) re-
mained as the inputs of the ANN classifier for PZ, and five 
features (sum average, minimum value, SD, 10th percentile, 
and entropy) were selected as the inputs of the ANN classi-
fier for CG. 
When comparing the performance of any selected fea-
tures alone, the sum average has the highest AUC and best 
accuracy in both PZ (AUC=0.831±0.029, accuracy of 0.794) 
and CG (AUC=0.718±0.044, accuracy of 0.755). After 
combining the selected features by the devised ANN classi-
fier, the AUC was 0.849±0.028 (95%, CI=0.7960.903)  
for the prediction of the CAD system in PZ, which was 
smaller than that of the T2WI scores (0.898±0.023 (95%, 
CI=0.8520.943)). AUC of the prediction of the CAD sys-
tem in CG (Figure 4B, AUC=0.821±0.038 (95%, CI= 
0.7460.895)) was also smaller than that of the T2WI 
scores (0.857±0.035 (95%, CI=0.7890.925)). By selecting 
appropriate cut-offs (0.688 for PZ, 0.725 for CG), the CAD 
prediction can reach high accuracy and specificity while 
maintaining acceptable sensitivity (0.652 for PZ, 0.654 for 
CG). The summary of the CAD performance and T2WI 
scores is shown in Table 5. 
3  Discussion 
This study made an indepth research into the prostate T2WI 
by a CAD system, which can differentiate malignancies 
from benign regions with an AUC of 0.849 in PZ and 0.821 
in CG. There is already a consensus that multi-parameter  
Table 4  The means and SDs of features extracted from T2-weighted images in PZ and CGa) 
Feature 
Peripheral zone Central gland 
PCa Non-PCa P-value PCa Non-PCa P-value 
Sum average 370.6±160.5 661.5±244.5 <0.01 355.5±112.0 463.4±154.8 <0.01 
Minimum value 298.6±142.8 508.5±216.5 <0.01 289.3±89.88 373.6±123.6 <0.01 
Standard deviation 35.74±15.56 68.14±34.79 <0.01 33.85±16.81 46.37±21.65 <0.01 
Coefficient of variation 11.18±4.30 11.19±4.98 0.982 11.84±4.350 11.04±3.513 0.194 
10th percentile 323.9±148.5 570.2±227.8 <0.01 313.4±98.05 404.9±135.1 <0.01 
Skewness 0.126±0.509 0.189±0.697 <0.01 0.256±0.447 0.212±0.591 0.627 
Kurtosis 2.736±0.699 3.019±1.366 0.067 2.742±0.812 2.912±1.045 0.291 
Contrast 1.077±0.439 0.842±0.379 <0.01 1.351±0.517 1.292±0.545 0.496 
Correlation 0.810±0.096 0.859±0.072 <0.01 0.770±0.088 0.776±0.098 0.683 
Energy 0.075±0.022 0.087±0.039 <0.01 0.065±0.018 0.072±0.023 0.076 
Homogeneity 0.675±0.060 0.711±0.068 <0.01 0.637±0.060 0.651±0.063 0.154 
Entropy 5.454±0.248 5.615±0.161 <0.01 5.446±0.229 5.535±0.200 <0.01 
a) *P values calculated by two-sample t-test were used to indicate the significance of the difference between features obtained in normal ROIs and can-
cerous ROIs. Data are mean±SD. 
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Figure 3  Importance of different images features in PZ (A) and CG (B). Mean, mean value; min, minimum value; std, standard deviation; cv, coefficient of 
variation; quantile 10, 10th percentile; contr, contrast; corr, correlation; homo, homogeneity; entro, entropy. 
Table 5  Summary of the CAD performance of different groupsa) 
Position Subject AUC (mean±std (95%, CI)) Cut-off Sensitivity Specificity PPV NPV Accuracy
PZ 
CAD prediction 0.849±0.028(0.7960.903) 0.688 0.652 0.897 0.800 0.804 0.803 
T2WI score 0.898±0.023(0.8520.943) 3.000 0.728 0.979 0.957 0.851 0.882 
CG 
CAD prediction 0.821±0.038(0.7460.895) 0.725 0.654 0.912 0.739 0.873 0.840 
T2WI score 0.857±0.035(0.7890.925) 3.000 0.596 0.941 0.795 0.859 0.846 
a) AUC, area under the curve; CI, confidence interval. 
diagnosis should be used [5,22] in prostate MR imaging. As 
far as we know, few papers have been published that fo-
cused on the basic prostate T2-weighted MR imaging by 
using CAD and introducing the image features in detail with 
corresponding clinical implications.  
Quantitative features extraction is the major difficulty 
affecting image processing and analysis. In this study, 12 
quantitative features were extracted from T2WI. Humans 
have limited ability to discover and deal with the complex 
relationship of so many features. ANNs are artificial intel-
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Figure 4  ROC curves for ROIs located in PZ (A) and CG (B). The purple curves stand for the performance of this CAD system and the blue curves indi-
cate the results of the T2WI scores. 
ligent systems that acquire knowledge through a learning 
process and use the knowledge to predict results from un-
seen information, like the processing of the human brain. 
Therefore, it has the potential capabilities to find the com-
plex interactions between the input variables and the out-
come. 
Viswanath et al. [29] indicated that CG and PZ prostate 
cancers and non-cancers have significantly different quanti-
tative and texture features on T2-weighted MR images. De-
tection of PCa by MR is most effective for tumours located 
in PZ, as an area of low signal intensity can be easily dif-
ferentiated from high-signal-intensity normal tissue. Tu-
mours in CG should be carefully sought, especially in the 
absence of a dominant tumour in PZ with increased PSA 
levels. In CG, hyperplastic nodules make the signal more 
complicated than that of PZ, and low signal intensity of PCa 
in T2WI is easily confused with hyperplastic nodules. A 
homogeneous low-signal-intensity region in CG is a very 
important finding that supports the diagnosis of a transition 
zone tumour [30]. Therefore, the characteristics of CG and 
PZ were separately extracted and analysed in our research. 
After selective optimisation of 12 features extracted from 
T2WI, the features were verified as valid to apply in com-
puter-aided PCa diagnosis. In PZ, 10 of the 13 features 
could distinguish PCa from non-PCa. But for CG, the num-
ber was only 5.  
The first three indicators of general features of both CG 
and PZ showed significant difference, and the coefficient of 
variation showed no obvious difference. For the sum aver-
age and the minimum, PCa both in CG and PZ appears as 
an area of low signal intensity in T2WI. It is easily differen-
tiated from high-signal-intensity normal PZ tissue, but often 
with some difficulty in CG regions. The minimum cannot 
be easily detected by the human eyes, especially in the hy-
perplasia region of CG. This is one of the advantages of 
CAD. The low signal intensity is always homogeneous in 
the cancer region, both in CG and PZ [31], which means the 
standard deviation in the cancer region is lower than that of 
non-PCa. 
The 10th percentile from the histogram showed an obvi-
ous difference between PCa and non-PCa, both in CG and 
PZ. As the cancer is always a homogeneous low signal in 
T2WI, the distribution of pixels in the cancerous region 
must be skewed.  
All the five features derived from the co-occurrence ma-
trix were significantly different between PCa and non-PCa 
in PZ, but only entropy was significantly different between 
PCa and non-PCa in CG. The underlying mechanism could 
be that the healthy prostate PZ consists of complicated tis-
sue structures with normal glandular morphology, whose 
complex architectures contribute to higher roughness fea-
tures on the T2-weighted MR images. The presence of PCa 
increases cellular density and changes microvasculature. As 
a result, the normal pattern is disrupted and the complexity 
of the ROI on the T2WI is reduced. Such a behaviour is also 
evident in Table 4, where relatively higher energy and en-
tropy can be found in cancerous ROIs compared with those 
of non-cancer ROIs. As a result, the texture features reflect 
the complexities at different levels for those cancerous pat-
terns. 
For PZ, sum average contributed the largest part in dis-
tinguishing PCa, while SD became the most important fea-
ture for CG. The result is also consistent with our clinical 
experience. PCa in PZ appears as an area of low signal  
intensity that is always easy to differentiate from high-  
signal-intensity normal tissue. For CG, homogeneity of the 
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low-signal-intensity region is a very important feature sup-
porting the diagnosis of PCa. It is worth noting that one of 
the texture features “entropy” ranked in third place. This 
means the lesions in CG with features of homogeniety, low 
signal intensity, and a disorganised state have a higher pos-
sibility of cancer. 
After combining the selected features by the devised 
ANN classifier, better results were achieved than by any 
feature alone. For PZ, the CAD system distinguished benign 
from malignant lesions with an AUC of 0.849 (95% 
CI=0.7960.903), while the AUC for CG was 0.821 (95% 
CI=0.7460.895). The results were not worse than previous 
studies using multi-parameter MR including diffusion 
weighted (DWI) and/or dynamic contrast-enhanced MRI 
(DCE). In the studies combining T2WI, DWI, and DCE 
images, values of 0.79 and 0.83 for overall AUC were 
achieved [24,32]. The results were worse than the results of 
our study, which only used T2WI. The relatively small 
number of patients may be the cause of the lower diagnosis 
accuracy. Hambrock et al. [33] got better AUC values of 
0.92 (95% CI=0.880.96) for PZ and 0.87 (95% 
CI=0.780.96) for CG.  
When compared with radiologists’ scores, the prediction 
results of CAD were a little lower, but the prediction accu-
racy was more than 80%, which was at an acceptable level. 
Because the two radiologists had 7 and 9 years of prostate 
MR diagnosis experience, they are very experienced. At 
present, the most important clinical value of the CAD sys-
tem is to assist radiologists in making decisions by provid-
ing an objective chance of malignancy for any suspicious 
lesion with high reliability and repeatability, especially for 
less-experienced doctors. This is especially important for 
those patients with a low risk of PCa and in no need of a 
biopsy. 
Time is an important issue for any techniques to be actu-
ally used in clinical practice. Many promising techniques 
have not been incorporated into clinical practice because 
they were time-consuming. This CAD system is time-saving 
and very efficient. Once the CAD system is ready, only a 
few seconds are needed for the result prediction, which is 
very convenient in clinical practice. Thus, diagnoses can be 
made more quickly and reliably. 
There are several limitations in our research. First, we 
aimed to compare the diagnosis performance of a feature set 
by this CAD system, though this was not the right way to 
distinguish prostate malignancy from a benign region only 
using T2WI. Second, ROI and pathology were not strictly 
correlated, although they were identified by two experi-
enced radiologists. Third, numbers of ROIs of cancer and 
non-cancer were not identical, so this may have resulted in a 
difference in the learning process. More ROIs will be used 
to train the ANN in later research in order to increase accu-
racy.  
In conclusion, with computer-aided analysis of T2WI, 
many characteristic features with different diagnostic capa-
bilities can be extracted. The outcome is convictive and 
helpful in medical diagnosis. 
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